| CTNNB1 |
Multiple congenital anomalies |
group |
Congenital Abnormality |
0.30 |
DisGeNET |
| CTNNB1 |
Adenocarcinoma |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Adenoma |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Adrenal Gland Neoplasms |
group |
Neoplastic Process |
0.31 |
DisGeNET |
| CTNNB1 |
Brain Neoplasms |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of breast |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Malignant Neoplasms |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Malignant tumor of colon |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of endometrium |
disease |
Neoplastic Process |
0.33 |
DisGeNET |
| CTNNB1 |
Cecal Neoplasms |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Uterine Cervical Neoplasm |
disease |
Neoplastic Process |
0.31 |
DisGeNET |
| CTNNB1 |
Colonic Neoplasms |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Colorectal Carcinoma |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Colorectal Neoplasms |
group |
Neoplastic Process |
0.50 |
DisGeNET |
| CTNNB1 |
Craniopharyngioma |
disease |
Neoplastic Process |
0.66 |
DisGeNET |
| CTNNB1 |
Toxic Epidermal Necrolysis |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Hemangiosarcoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Hepatitis, Toxic |
disease |
Injury or Poisoning |
0.30 |
DisGeNET |
| CTNNB1 |
Hepatoma, Morris |
disease |
Experimental Model of Disease; Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Hepatoma, Novikoff |
disease |
Experimental Model of Disease; Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Intestinal Neoplasms |
group |
Neoplastic Process |
0.32 |
DisGeNET |
| CTNNB1 |
Liver Cirrhosis |
disease |
Disease or Syndrome |
0.33 |
DisGeNET |
| CTNNB1 |
Liver neoplasms |
group |
Neoplastic Process |
0.37 |
DisGeNET |
| CTNNB1 |
Liver Neoplasms, Experimental |
group |
Experimental Model of Disease; Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Lung Neoplasms |
group |
Neoplastic Process |
0.33 |
DisGeNET |
| CTNNB1 |
Medulloblastoma |
disease |
Neoplastic Process |
0.80 |
DisGeNET |
| CTNNB1 |
melanoma |
disease |
Neoplastic Process |
0.50 |
DisGeNET |
| CTNNB1 |
Muscular Atrophy |
phenotype |
Pathologic Function |
0.30 |
DisGeNET |
| CTNNB1 |
Neoplasm Invasiveness |
phenotype |
Pathologic Function |
0.30 |
DisGeNET |
| CTNNB1 |
Neoplasm Metastasis |
phenotype |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Nephroblastoma |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Nerve Degeneration |
phenotype |
Cell or Molecular Dysfunction |
0.30 |
DisGeNET |
| CTNNB1 |
Ovarian Carcinoma |
disease |
Neoplastic Process |
0.36 |
DisGeNET |
| CTNNB1 |
Pancreatic Neoplasm |
disease |
Neoplastic Process |
0.33 |
DisGeNET |
| CTNNB1 |
Peritoneal Neoplasms |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Prostatic Neoplasms |
group |
Neoplastic Process |
0.58 |
DisGeNET |
| CTNNB1 |
Salivary Gland Neoplasms |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Schizophrenia |
disease |
Mental or Behavioral Dysfunction |
0.33 |
DisGeNET |
| CTNNB1 |
Stevens-Johnson Syndrome |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Fibromatosis, Aggressive |
disease |
Neoplastic Process |
0.70 |
DisGeNET |
| CTNNB1 |
Experimental Hepatoma |
disease |
Experimental Model of Disease; Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Cutaneous Melanoma |
disease |
Neoplastic Process |
0.43 |
DisGeNET |
| CTNNB1 |
Adenocarcinoma of lung (disorder) |
disease |
Neoplastic Process |
0.41 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of cecum |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of brain |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adenocarcinoma, Basal Cell |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adenocarcinoma, Oxyphilic |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Carcinoma, Cribriform |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Carcinoma, Granular Cell |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adenocarcinoma, Tubular |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adenoma, Basal Cell |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Follicular adenoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adenoma, Microcystic |
disease |
Neoplastic Process |
0.31 |
DisGeNET |
| CTNNB1 |
Adenoma, Monomorphic |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Papillary adenoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adenoma, Trabecular |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Medullomyoblastoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Hepatoblastoma |
disease |
Neoplastic Process |
0.70 |
DisGeNET |
| CTNNB1 |
Adrenal Cortical Adenoma |
disease |
Neoplastic Process |
0.37 |
DisGeNET |
| CTNNB1 |
Hepatocellular Adenoma |
disease |
Neoplastic Process |
0.35 |
DisGeNET |
| CTNNB1 |
Adrenocortical carcinoma |
disease |
Neoplastic Process |
0.43 |
DisGeNET |
| CTNNB1 |
Pilomatrixoma |
disease |
Neoplastic Process |
0.75 |
DisGeNET |
| CTNNB1 |
No-Reflow Phenomenon |
phenotype |
Finding |
0.30 |
DisGeNET |
| CTNNB1 |
Disease Exacerbation |
phenotype |
Finding |
0.30 |
DisGeNET |
| CTNNB1 |
Fibrosis, Liver |
disease |
Disease or Syndrome |
0.40 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of lung |
disease |
Neoplastic Process |
0.39 |
DisGeNET |
| CTNNB1 |
Parathyroid Adenoma |
disease |
Neoplastic Process |
0.34 |
DisGeNET |
| CTNNB1 |
Neurogenic Muscular Atrophy |
phenotype |
Pathologic Function |
0.30 |
DisGeNET |
| CTNNB1 |
Childhood Medulloblastoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Gastric Adenocarcinoma |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Adult Craniopharyngioma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adult Medulloblastoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Childhood Hepatocellular Carcinoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adult Hepatocellular Carcinoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Squamous cell carcinoma of esophagus |
disease |
Neoplastic Process |
0.41 |
DisGeNET |
| CTNNB1 |
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse |
disease |
Neoplastic Process |
0.31 |
DisGeNET |
| CTNNB1 |
Familial Exudative Vitreoretinopathy |
disease |
Congenital Abnormality |
0.30 |
DisGeNET |
| CTNNB1 |
Vascular calcification |
phenotype |
Pathologic Function |
0.30 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of liver |
disease |
Neoplastic Process |
0.37 |
DisGeNET |
| CTNNB1 |
Malignant mesothelioma |
disease |
Neoplastic Process |
0.32 |
DisGeNET |
| CTNNB1 |
Carcinoma in situ of endometrium |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Intestinal Cancer |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of pancreas |
disease |
Neoplastic Process |
0.31 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of prostate |
disease |
Neoplastic Process |
0.60 |
DisGeNET |
| CTNNB1 |
Craniofacial Abnormalities |
group |
Congenital Abnormality |
0.30 |
DisGeNET |
| CTNNB1 |
Papillary craniopharyngioma |
disease |
Neoplastic Process |
0.33 |
DisGeNET |
| CTNNB1 |
Adamantinous Craniopharyngioma |
disease |
Neoplastic Process |
0.37 |
DisGeNET |
| CTNNB1 |
Primary microcephaly |
disease |
Congenital Abnormality |
0.30 |
DisGeNET |
| CTNNB1 |
Endometrial Carcinoma |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| CTNNB1 |
Neoplasm of uncertain or unknown behavior of ovary |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Epithelial ovarian cancer |
disease |
Neoplastic Process |
0.34 |
DisGeNET |
| CTNNB1 |
Breast Carcinoma |
disease |
Neoplastic Process |
0.50 |
DisGeNET |
| CTNNB1 |
Colon Carcinoma |
disease |
Neoplastic Process |
0.50 |
DisGeNET |
| CTNNB1 |
Adrenal Cancer |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Craniopharyngioma, Child |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Desmoplastic Medulloblastoma |
disease |
Neoplastic Process |
0.50 |
DisGeNET |
| CTNNB1 |
Lymphoma, Lymphocytic, Intermediate |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Drug-Induced Liver Disease |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
ovarian neoplasm |
disease |
Neoplastic Process |
0.84 |
DisGeNET |
| CTNNB1 |
Malignant neoplasm of ovary |
disease |
Neoplastic Process |
0.81 |
DisGeNET |
| CTNNB1 |
Mammary Neoplasms, Human |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Hepatitis, Drug-Induced |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Drug-Induced Stevens Johnson Syndrome |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Melanotic medulloblastoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Adenocarcinoma of large intestine |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Medulloblastoma with extensive nodularity |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
Mammary Neoplasms |
group |
Neoplastic Process |
0.39 |
DisGeNET |
| CTNNB1 |
Colorectal Cancer |
disease |
Neoplastic Process |
0.60 |
DisGeNET |
| CTNNB1 |
Neurodevelopmental Disorders |
group |
Mental or Behavioral Dysfunction |
0.30 |
DisGeNET |
| CTNNB1 |
Exudative vitreoretinopathy 1 |
disease |
Disease or Syndrome |
0.40 |
DisGeNET |
| CTNNB1 |
Aberrant Crypt Foci |
phenotype |
Finding |
0.30 |
DisGeNET |
| CTNNB1 |
Liver carcinoma |
disease |
Neoplastic Process |
0.80 |
DisGeNET |
| CTNNB1 |
Bilateral Wilms Tumor |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
MENTAL RETARDATION, AUTOSOMAL DOMINANT 19 |
disease |
Disease or Syndrome |
0.70 |
DisGeNET |
| CTNNB1 |
Drug-Induced Acute Liver Injury |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Mycoplasma-Induced Stevens-Johnson Syndrome |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Intellectual Disability |
group |
Mental or Behavioral Dysfunction |
0.44 |
DisGeNET |
| CTNNB1 |
cervical cancer |
disease |
Neoplastic Process |
0.31 |
DisGeNET |
| CTNNB1 |
Chemical and Drug Induced Liver Injury |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Chemically-Induced Liver Toxicity |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| CTNNB1 |
Peritoneal Surface Malignancy |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| CTNNB1 |
EXUDATIVE VITREORETINOPATHY 7 |
disease |
Disease or Syndrome |
0.40 |
DisGeNET |